document type sequence filename description text html head head body lang style font family time roman align right style margin text align right font size face time roman style font size font weight bold exhibit font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold license agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold this license agreement font font size style font size style font weight bold agreement effective december nbsp nbsp nbsp nbsp nbsp style font weight bold effective date made between chimerix nbsp corporation organized existing under state delaware style font weight bold chimerix contravir pharmaceutical nbsp corporation organized existing under state delaware style font weight bold contravir font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold recital font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold whereas font font size style font size chimerix owns otherwise control patent patent application know other information relating compound known font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold whereas font font size style font size contravir engaged discovery development antiviral therapy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold whereas font font size style font size contravir desire obtain chimerix willing grant contravir license under chimerix technology develop make have made sell offer sale export import compound product field term subject condition forth herein font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold therefore font font size style font size consideration foregoing premise mutual covenant contained herein receipt sufficiency which hereby acknowledged party hereby agree follows font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold definition font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size unless specifically forth contrary herein following term shall have respective meaning forth below font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold accounting standard font font size style font size shall mean nbsp generally accepted accounting principle nbsp international financial reporting standard either case consistently applied throughout organization party related party applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold acquirer compound font font size style font size shall mean font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size converting compound that controlled third party acquirer chimerix affiliate such third party acquirer immediately prior such third party acquirer acquisition chimerix font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size converting compound that controlled third party acquirer chimerix affiliate such third party acquirer following such third party acquirer acquisition chimerix provided that such converting compound nbsp invented reduced practice without chimerix know including chimerix font style margin font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size confidential proprietary information existing prior such third party acquisition chimerix nbsp claimed chimerix patent right forth exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean applicable united state federal food drug cosmetic public health service such amended from time time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold affiliate font font size style font size shall mean with respect person other person that directly indirectly control controlled under common control with such person person shall deemed control another person such person posse power direct cause direction management business policy such person whether through ownership more voting security such person contract otherwise clarity once person cease affiliate party then without further action such person shall cease have right under this agreement reason being affiliate such party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold applicable font font size style font size shall mean applicable jurisdiction which applicable party their respective affiliate carrying activity hereunder which party their respective affiliate carrying activity hereunder subject shall include statute enactment legislature ordinance rule regulation notification guideline policy direction directive order statutory authority tribunal board court central state government local authority other governmental entity such jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix know font font size style font size shall mean know controlled chimerix affiliate effective date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix patent right font font size style font size shall mean patent right controlled chimerix affiliate effective date time during term that claim cover composition matter manufacture compound product excluding claim solely specifically claiming composition matter manufacture other active chimerix patent right shall include chimerix affiliate right joint patent right chimerix patent right shall include those listed exhibit nbsp notwithstanding foregoing chimerix patent right shall include patent controlled third party acquirer chimerix affiliate such third party acquirer except such patent claiming invention made such third party acquirer affiliate after such third party acquirer acquisition chimerix through nbsp chimerix know nbsp practice invention that then covered valid patent claim chimerix patent right listed exhibit nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix product font font size style font size shall mean nbsp compound product treatment prevention excluded indication nbsp excluded product treatment prevention indication font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix technology font font size style font size shall mean chimerix patent right chimerix know font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix patent right font font size style font size shall have meaning provided section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold combination product font font size style font size shall mean product which includes more other active combination with compound including fixed dose combination product reference product this agreement shall deemed include combination product provided however that nothing contained this agreement shall construed grant convey contravir license other right other active font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold commercially reasonable effort font font size style font size shall mean with respect effort expended party with respect objective level reasonable diligent good faith effort that biopharmaceutical company typically devote product owned them that similar stage their development product life similar market potential taking into account efficacy safety approved labeling competitiveness alternative product marketplace patent other proprietary position product likelihood regulatory approval profitability product other relevant factor used this section nbsp biopharmaceutical company shall mean company biopharmaceutical industry size stage development similar that such party including having human pharmaceutical product candidate product similar stage development compound commercially reasonable effort shall determined market market product product basis anticipated that level effort will different different market will change over time reflecting change status product market nbsp involved font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compound font font size style font size shall mean font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size hexadecyloxy propyl hydrogen amino purin propan yloxy methyl phosphonate known font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size converting compound that controlled chimerix effective date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size converting compound that controlled chimerix that synthesized generated after effective date during term excluding acquirer compound font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size metabolite compound excluding acquirer compound described preceding subparagraphs nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size prodrug conjugate complex compound excluding acquirer compound described preceding subparagraphs nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size salt free acid base solvate enantiomer isomer hydrate ester racemate polymorphic form compound excluding acquirer compound described preceding subparagraphs nbsp font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size compound shall mean font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold confidential information font font size style font size shall mean information whether communicated writing orally other method which provided behalf party other party connection with this agreement pursuant that certain mutual disclosure agreement between party dated june nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir know font font size style font size shall mean know controlled contravir affiliate other than result virtue license granted chimerix contravir under this agreement during term including know developed generated behalf contravir affiliate course conducting research development manufacturing regulatory commercialization activity contemplated this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir patent right font font size style font size shall mean patent right controlled contravir affiliate other than result virtue license granted chimerix contravir under this agreement during term that claim cover composition matter manufacture compound product contravir patent right shall include contravir affiliate right joint patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold control font font size style font size control controlled shall mean with respect patent right nbsp information know other intellectual property right possession person ability whether ownership license other right style font style italic other than pursuant license granted under this agreement grant access license sublicense such patent right know nbsp information other intellectual property right without violating term agreement other arrangement with other person font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold converting compound font font size style font size shall mean pharmaceutically active compound that converted nbsp vivo into active moiety tenofovir diphosphate understood that converting compound font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cover font font size style font size mean nbsp with respect know such know used exploitation product nbsp with respect patent right valid patent claim would absent license thereunder ownership thereof infringed exploitation product including research development cognate word cover shall have correlative meaning font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold ebola font font size style font size shall mean ebola virus infection ebola virus disease font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean european medicine agency successor entity thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold approval font font size style font size shall mean nbsp approval product particular indication relevant regulatory authority least nbsp market nbsp required marketing such product such indication such nbsp market receipt pricing reimbursement approval such product such indication such nbsp market font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold market font font size style font size shall mean european union member state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold excluded indication font font size style font size shall mean treatment prevention ebola font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold excluded product font font size style font size shall mean topical dosage form containing compound with without other active font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold export control font font size style font size shall mean applicable regulation relating nbsp sanction embargo imposed office foreign asset control department treasury nbsp export export commodity technology service including export administration international emergency economic power trading with enemy export control international boycott provision section nbsp internal revenue code amended font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold fcpa font font size style font size shall mean foreign corrupt practice amended font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean food drug administration successor entity thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold field font font size style font size shall mean compound product treatment prevention indication specifically style font style italic excluding nbsp compound product treatment prevention excluded indication nbsp excluded product treatment prevention indication font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold first commercial sale font font size style font size shall mean with respect given product given country first commercial transfer disposition value such product contravir related party third party other than related party consumption such product such country after receipt marketing approval such product such country excluding however transfer disposition product without consideration nbsp connection with patient assistance program nbsp charitable promotional purpose nbsp preclinical clinical regulatory governmental purpose under called named patient other limited access program nbsp test study reasonably necessary comply with applicable regulation request regulatory authority clarity first commercial sale shall determined product product country country basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold generic version font font size style font size shall mean with respect product country country basis pharmaceutical product that nbsp sold given country third party other than related party licensee sublicensee related party other person chain distribution originating from contravir related party their respective licensee sublicensees nbsp contains same compound applicable same other active such product same dosage form such product nbsp been approved marketing relevant regulatory authority such country reliance marketing approval such product such country including such pharmaceutical product that been approved font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size marketing nbsp united state pursuant section nbsp nbsp section nbsp nbsp nbsp respectively nbsp european union european union member state generic medicinal product pursuant article nbsp parliament council directive amended including application under article nbsp parliament council regulation that relies content such provision nbsp other country jurisdiction pursuant equivalent foregoing regulation directive wherein approval such pharmaceutical product based reference marketing approval such product such country demonstration equivalence such product which substituted product without action physician health care practitioner font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean then current good clinical practice such term defined from time time other regulatory authority competent jurisdiction pursuant regulation guideline otherwise applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean then current good laboratory practice such term defined from time time other regulatory authority competent jurisdiction pursuant regulation guideline otherwise applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean then current good manufacturing practice such term defined from time time other regulatory authority competent jurisdiction pursuant regulation guideline otherwise applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size mean international conference harmonisation technical requirement registration pharmaceutical human font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean investigational drug application clinical study application clinical trial exemption similar application submission approval conduct human clinical investigation filed with submitted regulatory authority conformance with requirement such regulatory authority including such application filed with pursuant part nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold indication font font size style font size shall mean separate distinct disease medical condition human nbsp which product intended treat prevent evidenced protocol clinical trial such product proposed product labeling filed with regulatory authority such product nbsp which contained product labeling approved regulatory authority part marketing approval such product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold information font font size style font size shall mean proprietary data information material know whether patentable that public domain including nbsp idea discovery invention improvement technology trade secret nbsp pharmaceutical chemical biological material product component composition nbsp method procedure formula process test assay technique regulatory requirement strategy nbsp biological chemical pharmacological toxicological pharmaceutical physical analytical clinical safety manufacturing quality control data information related thereto nbsp technical technical data other information related foregoing font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp drawing plan design diagram sketch specification other document containing relating such information material font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size infringe infringement mean infringement determined applicable including without limitation direct infringement contributory infringement inducement infringe font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold initiate font font size style font size initiation shall mean with respect human clinical trial administration first dose first patient subject such trial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold invention font font size style font size shall mean invention whether patentable made course result conduct activity contemplated this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint invention font font size style font size shall have meaning provided section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint patent right font font size style font size shall have meaning provided section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold know font font size style font size shall mean information related compound product formulation product improvement indication thereof necessary useful development manufacture commercialization foregoing excluding each case nbsp information related other active font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold marketing approval font font size style font size shall mean approval from relevant regulatory authority given country necessary market sell pharmaceutical product such country including pricing reimbursement approval required marketing sale such product such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold merck font font size style font size shall mean merck sharp dohme corp affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold merck agreement font font size style font size shall mean that certain collaboration exclusive license agreement between chimerix merck sharp dohme corp dated july nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean nbsp united state drug application more fully defined nbsp filed with successor application thereto nbsp other country group country equivalent application submission approval market pharmaceutical product filed with governing regulatory authority such country group country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold sale font font size style font size shall mean gross amount invoiced sale other disposition product behalf contravir related party each style font weight bold selling party third party other than related party following deduction actually incurred allowed paid accrued otherwise specifically allocated product selling party compliance with applicable accounting standard consistently applied selling party font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size normal customary trade discount including trade cash quantity discount rebate credit refund actually allowed taken font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size credit allowance actually granted made rejection return previously sold product including recall retroactive price reduction billing error stocking allowance font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size governmental other rebate credit other equivalent thereof actually granted managed health care organization commercial insurance company pharmacy benefit manager equivalent thereof distributor national state provincial local other government their agency purchaser reimbursers trade customer font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size reasonable paid wholesaler distributor selling agent excluding sale representative selling party group purchasing organization third party payors other contractees managed care entity each case with respect product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size charge separately invoiced freight insurance transportation postage handling font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size custom duty other governmental charge including such value added similar government charge excluding what commonly known income levied measured billing amount product adjusted rebate refund font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size debt provision debt deduction actually written during applicable accounting period following applicable accounting standard used selling party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size event shall particular amount identified above deducted more than once calculating sale double counting deduction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size country country basis product under this agreement sold form combination product country sale purpose determining royalty hereunder shall calculated follows font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size where active ingredient such combination product sold separately such country sale shall calculated multiplying actual sale such combination product such country determined under first paragraph this section nbsp fraction where invoice price product sold separately such country invoice price other active nbsp combination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size product component combination product sold separately such country none such other active nbsp sold separately such country sale shall calculated multiplying actual sale such combination product font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size such country determined under first paragraph this section nbsp fraction where invoice price such product component sold separately such country invoice price combination product such country font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size product component combination product sold separately such country other active nbsp sold separately such country sale shall calculated multiplying actual sale such combination product such country determined under first paragraph this section nbsp fraction where invoice price combination product such country invoice price charged other active nbsp combination product such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size none product component other active nbsp sold separately such country sale purpose determining royalty hereunder combination product shall determined mutual agreement party good faith taking into account perceived relative value contribution compound product portion combination product other active nbsp combination product provided however that event shall relative value contribution compound product portion combination product than case disagreement independent expert agreed upon both party failing such agreement designated international chamber commerce shall determine such relative value contribution such determination shall final binding upon party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size event product bundled sale together with more other product country style font weight bold product bundle then sale such product sold under such arrangement shall determined country country basis mutual agreement party good faith taking into account relative value contribution product other product product bundle reflected their individual sale price case disagreement independent expert agreed upon both party failing such agreement international chamber commerce shall determine such relative value contribution such determination shall final binding upon party addition selling party provides discount allowance with respect product bundle such discount allowance shall allocated purpose deduction used calculating sale above between product other product product bundle manner that unfairly inappropriately bias level discounting against product compared other product such product bundle font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size clarification sale product selling party another selling party resale such entity third party other than related party shall deemed sale purpose this definition sale provided that subsequent resale included computation sale further transfer disposition product without consideration nbsp connection with patient assistance program nbsp charitable promotional purpose nbsp preclinical clinical regulatory governmental purpose under called named patient other limited access program nbsp test study reasonably necessary comply with applicable regulation request regulatory authority shall font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size each case nbsp through deemed sale such product purpose this definition sale font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold other active font font size style font size shall mean active pharmaceutical ingredient that compound font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold party font font size style font size shall mean contravir chimerix individually party shall mean contravir chimerix collectively font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent right font font size style font size shall mean nbsp patent patent application which purpose this agreement shall deemed include certificate invention application certificate invention nbsp divisionals continuation continuation part reissue renewal substitution registration examination revalidations extension supplementary protection certificate like such patent patent application nbsp foreign equivalent foregoing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold person font font size style font size mean individual partnership joint venture limited liability company corporation firm trust association unincorporated organization governmental authority agency other entity specifically listed herein font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold phase nbsp clinical trial font font size style font size shall mean human clinical trial product country designed nbsp establish that such product safe efficacious intended nbsp define warning precaution adverse reaction that associated with product dosage range prescribed nbsp support regulatory approval such product that would satisfy requirement nbsp equivalent font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold pivotal trial font font size style font size shall mean nbsp phase nbsp clinical trial nbsp other human clinical trial that applicable regulatory authority agreed whether before initiation such trial nbsp pursuant special protocol assessment agreement with after initiation such trial based interim data analysis sufficient form primary basis efficacy claim submission regardless whether sponsor such trial characterizes refers such trial phase nbsp phase nbsp phase nbsp trial otherwise applicable protocol clinicaltrials other context human clinical trial constitute pivotal trial time initiation such trial later determined applicable regulatory authority sufficient form primary basis efficacy claim submission then purpose section nbsp hereof notwithstanding section nbsp initiation such pivotal trial shall deemed have occurred date such determination applicable regulatory authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold product font font size style font size shall mean pharmaceutical composition preparation dosage form final form containing compound including combination product excluding event excluded product clarity different formulation dosage strength given product shall considered same product purpose this agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold regulatory authority font font size style font size shall mean country federal supranational state local regulatory agency department bureau other governmental regulatory authority having administrative authority regulate development marketing pharmaceutical product country other jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold regulatory documentation font font size style font size shall mean regulatory application registration license authorization approval including inds ndas marketing approval correspondence submitted received from regulatory authority including minute official contact report relating communication with regulatory authority report documentation connection with clinical study test including study report study protocol copy interim study analysis data contained foregoing including inds ndas advertising promotion document manufacturing data drug master file clinical data adverse event file complaint file each case related compound product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold regulatory exclusivity font font size style font size shall mean marketing manufacturing exclusivity conferred applicable regulatory authority country jurisdiction holder marketing approval pharmaceutical product such country jurisdiction including example limitation regulatory data exclusivity orphan drug exclusivity chemical entity exclusivity pediatric exclusivity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold related party font font size style font size shall mean each contravir affiliate their respective sublicensees hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty term font font size style font size shall have meaning provided section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold sublicensee font font size style font size shall mean third party sublicensee under license granted chimerix contravir pursuant section nbsp whether such third party sublicense granted directly contravir affiliate indirectly through more tier sublicense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold term font font size style font size shall have meaning provided section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size territory shall mean entire world font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold third party font font size style font size shall mean entity other than contravir affiliate chimerix affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold third party acquirer font font size style font size shall have meaning provided section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold font font size style font size shall mean regent university california font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold license font font size style font size shall mean that certain license agreement dated nbsp between chimerix amended september nbsp december nbsp september nbsp july nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold valid patent claim font font size style font size shall mean claim issued unexpired patent included within chimerix patent right which claim been revoked held unenforceable invalid decision court other governmental agency competent jurisdiction which decision appealable been appealed within time allowed appeal which claim been disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold license grant font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold license grant font font size style font size subject term condition this agreement chimerix hereby grant contravir nbsp exclusive even chimerix affiliate royalty bearing license including right sublicense through multiple tier sublicense under chimerix patent right chimerix know that specific compound product nbsp exclusive royalty bearing license including right sublicense through multiple tier sublicense under chimerix know that specific compound product each case solely discover develop make have made sell have sold offer sale market export import otherwise commercialize compound product field territory during term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold sublicensing font font size style font size sublicense granted contravir under this agreement directly indirectly through affiliate third party shall nbsp writing nbsp subject subordinate respect consistent with term condition this agreement with respect chimerix patent right applicable term condition license contravir shall provide chimerix with copy sublicense agreement entered into contravir affiliate amendment thereto within nbsp execution contravir shall liable failure sublicensees comply with relevant obligation under this agreement shall cost enforce compliance sublicensees with term sublicense agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold technology transfer font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold inventory font font size style font size within nbsp after effective date subject chimerix receipt preferred stock defined section nbsp this agreement chimerix shall transfer contravir additional cost contravir chimerix existing inventory bulk compound bulk product including such inventory held contract manufacturer chimerix collectively style font weight bold inventory provided that chimerix retain provide chimerix academic collaborator such limited quantity inventory exceed kilogram necessary conduct planned clinical trial more topical dosage form compound exhibit nbsp attached hereto forth chimerix good faith estimate available inventory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold manufacturing technology transfer font font size style font size within nbsp after effective date subject chimerix receipt preferred stock chimerix shall transfer cause transferred including from third party contract manufacturer contravir font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size third party manufacturer designated contravir copy chimerix know related manufacture compound chimerix control whether possession chimerix affiliate third party contract manufacturer order enable contravir designee manufacture compound field using process employed behalf chimerix manufacture compound provided however that chimerix shall have obligation transfer disclose contravir chimerix know related manufacture chimerix product except extent such chimerix know also relates manufacture product addition font font size style font size chimerix shall provide contravir with introduction chimerix third party contract manufacturer nbsp compound shall deliver such contract manufacturer nbsp written authorization nbsp contract with contravir manufacture supply compound nbsp manufacture compound behalf contravir nbsp disclose contravir such chimerix know regarding manufacture compound possession such contract manufacturer necessary useful contravir manufacture have manufactured compound product field font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix know font font size style font size within nbsp after effective date subject chimerix receipt preferred stock chimerix shall transfer contravir clinical safety toxicology other data within chimerix know related compound chimerix possession control whether generated behalf chimerix received from merck that available written graphic electronic other tangible form true complete copy thereof extent such data exists electronic form chimerix provide same contravir electronic form font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold technical assistance font font size style font size during twelve month period beginning effective date style font weight bold technical assistance period contravir request chimerix shall provide reasonable technical assistance contravir practice chimerix know transferred contravir pursuant this section nbsp style font weight bold technical assistance clarity technical assistance excludes performance additional research development manufacturing including work total nbsp person hour technical assistance exceed nbsp hour month will provided chimerix expense time excess nbsp person hour spent chimerix personnel providing technical assistance requested contravir contravir shall reimburse chimerix rate person hour chimerix shall commercially reasonable effort provide additional technical assistance event shall chimerix obligated provide more than aggregate nbsp person hour additional technical assistance pursuant this section nbsp provide technical assistance pursuant this section nbsp nbsp after technical assistance period except each case upon mutual written agreement party should contravir request chimerix agree provide technical assistance location other than chimerix facility contravir shall also reimburse reasonable travel lodging expense incurred chimerix providing such technical assistance additional technical assistance font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold regulatory documentation font font size style font size within nbsp after effective date subject chimerix receipt preferred stock chimerix shall transfer assign contravir regulatory documentation chimerix affiliate control including transfer assignment contravir font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold reserved right font font size style font size chimerix hereby expressly reserve exclusive right practice grant license under chimerix technology purpose other than specific purpose which chimerix technology exclusively licensed contravir under section nbsp without limiting generality foregoing chimerix hereby expressly reserve exclusive right practice grant license under chimerix technology discover develop make have made sell have sold offer sale market import export otherwise commercialize nbsp chimerix product nbsp compound that compound product containing compound that compound containing compound including without limitation brincidofovir addition contravir acknowledges that chimerix patent right subject nbsp agreement sponsor right such term defined license nbsp reserved right under license nbsp dana farber cancer institute reserved right under license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold negative covenant font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir font font size style font size contravir hereby covenant practice permit cause related party other third party practice chimerix technology purpose other than expressly authorized this agreement without limiting generality foregoing contravir shall directly indirectly font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size develop make have made sell have sold offer sale export import otherwise commercialize chimerix product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size permit cause related party third party engage activity described preceding clause nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix font font size style font size chimerix hereby covenant practice permit cause affiliate licensee other third party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size practice contravir patent right purpose other than expressly authorized section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size develop make have made sell have sold offer sale export import otherwise commercialize compound product other than excluded indication excluded product chimerix product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold license grant back chimerix font font size style font size subject term condition this agreement contravir hereby grant chimerix limited exclusive worldwide royalty free fully paid license with right sublicense through multiple tier under contravir patent right solely develop make have made sell have sold offer sale export import otherwise commercialize nbsp chimerix product nbsp brincidofovir font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold adjustment conversion font font size style font size event that during period market where contravir affiliate licensee marketing product chimerix font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size affiliate licensee then marketing nbsp chimerix product covered clause nbsp nbsp section nbsp either party determines that there objective evidence substantial label other party product such market which label adversely affect sale such party product indication which this agreement contemplates such party would granted retain case marketing right upon request such party party will negotiate good faith appropriate economic compensation paid party whose sale being adversely affected with objective preserving near economic outcome contemplated this agreement during such period such territory font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold implied license font font size style font size right license under patent right know other information granted shall granted implication such right license shall granted only expressly provided term this agreement avoidance doubt chimerix grant contravir license other right with respect active pharmaceutical ingredient that compound contravir grant chimerix license other right with respect other contravir intellectual property except described section nbsp applicable section nbsp font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold development manufacturing commercialization font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold responsibility font font size style font size contravir itself with through related party shall solely responsible expense shall control aspect worldwide development including clinical clinical development manufacture registration commercialization including marketing promoting selling distributing determining pricing compound product field territory without limiting generality foregoing contravir itself with through related party shall solely responsible preparing submitting required regulatory filing connection with obtaining maintaining marketing approval with respect compound product field territory including inds ndas contravir sole expense such submission other regulatory filing relating compound product field shall submitted name owned contravir related party applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold diligence font font size style font size contravir itself with through related party shall commercially reasonable effort develop seek marketing approval commercialize least product least indication field nbsp united state nbsp least three nbsp market font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold record font font size style font size contravir shall maintain cause maintained complete accurate record development work conducted behalf contravir with respect compound product including result data invention development made performance such development work such record maintained shall sufficient detail good scientific manner appropriate patent regulatory purpose font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold meeting report font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold meeting font font size style font size prior initiation first phase nbsp clinical trial product party shall chimerix written request more than quarterly hold periodic meeting telephone videoconference unless otherwise agreed which qualified representative contravir responsible product development will report chimerix respond chimerix reasonable question regarding progress result contravir product development registration effort font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold report font font size style font size before june nbsp december nbsp each year during term after initiation first phase nbsp clinical trial product contravir shall deliver chimerix semi annual written progress report nbsp summarizing status product development effort contravir related party including indication which them developing product nbsp disclosing submitted marketing approval obtained behalf contravir related party with respect product including applicable indication nbsp summarizing product commercialization activity undertaken planned behalf contravir related party with respect product each case preceding nbsp month contravir shall promptly respond chimerix reasonable written request inquiry relating written progress report provided hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compliance with applicable font font size style font size contravir shall conduct shall cause related party conduct development regulatory manufacturing commercialization activity with respect compound product anywhere world compliance with applicable applicable font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold payment font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold upfront equity issuance font font size style font size partial consideration right license granted contravir hereunder contravir shall issue chimerix soon practicable following effective date event later than five nbsp business thereafter nbsp share contravir series nbsp convertible preferred stock value style font weight bold preferred stock preferred stock shall nbsp have right preference privilege forth certificate designation preference right series nbsp convertible preferred stock filed with secretary state state delaware form attached hereto exhibit nbsp nbsp issued chimerix pursuant term subscription agreement form attached hereto exhibit nbsp contravir failure issue preferred stock contravir within five nbsp business effective date shall render this agreement null void nbsp initio font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold milestone payment font font size style font size within nbsp first achievement each milestone event forth table below contravir related party contravir shall provide chimerix with written notice such achievement shall chimerix corresponding time refundable creditable milestone payment forth below font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold milestone nbsp event font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width colspan valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone nbsp payment font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width style margin text indent font size face time roman style font size initiation first pivotal trial product font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff border none border solid windowtext padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size first font font size style font size approval product indication style font weight bold first indication font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width align right style margin text align right font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size first approval indication style font weight bold first indication font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size first commercial sale product market font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width align right style margin text align right font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size first approval product indication other than first indication font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin text indent font size face time roman style font size first approval product indication other than first indication font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom style padding width align right style margin text align right font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size each above milestone payment shall only paid once first achievement corresponding milestone event product regardless number time such milestone event achieved product number indication which such milestone event achieved product number product that achieve such milestone event regardless whether such milestone event achieved same product that achieved other milestone event different product font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold commercial nbsp milestone nbsp event font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width colspan valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold commercial milestone nbsp payment font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width style margin text indent font size face time roman style font size first calendar year which annual sale product territory exceed font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff border none border solid windowtext padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width style margin text indent font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size nbsp font width colspan valign bottom style padding width align right style margin text align right font size face time roman style font size nbsp font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size first calendar year which annual sale product territory exceed font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size each foregoing commercial milestone payment will paid only once first calendar year which corresponding commercial milestone event achieved will within nbsp after calendar year which such commercial milestone event achieved font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty font font size style font size subject section nbsp below contravir shall royalty chimerix aggregate annual sale product territory contravir related party each calendar year applicable rate nbsp forth below font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size certain information this page nbsp been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold annual nbsp nbsp sale nbsp increment font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty rate font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width style margin text indent font size face time roman style font size that portion annual sale product contravir related party that than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff border none padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bottom style padding width style margin text indent font size face time roman style font size that portion annual sale product contravir related party that greater than than equal font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign bottom style padding width align right style margin text align right font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin text indent font size face time roman style font size that portion annual sale product contravir related party that greater than font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bottom bgcolor cceeff style background cceeff padding width align right style margin text align right font size face time roman style font size font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold royalty term font font size style font size royalty under section shall payable product product country country basis during period time commencing first commercial sale product country ending upon latest nbsp nbsp year from date first commercial sale such product such country nbsp expiration regulatory exclusivity such product such country nbsp expiration last expire valid patent claim chimerix patent right covering manufacture sale such product such country style font weight bold royalty term product product country country basis upon expiration royalty term product country contravir license under section nbsp with respect such product such country shall become fully paid irrevocable perpetual font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold third party license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold license font font size style font size chimerix shall solely responsible making payment that become payable under license result commercialization product field contravir related party font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold additional third party license font font size style font size event that contravir determines that necessary obtain more license under issued unexpired patent right third party excluding sublicensees order make have made offer sell sell import compound contained product country style font weight bold third party patent license royalty actually paid third party under such third party patent license contravir sale such product such country calendar quarter shall creditable against royalty payment chimerix contravir with respect sale such product such country such calendar quarter provided however that event shall royalty otherwise owed contravir chimerix such calendar quarter such country reduced more than result such offset aggregate portion royalty paid third party under such third party patent license with respect such product such country that contravir would foregoing limitation royalty reduction entitled deduct under this section nbsp nbsp shall carried over applied against royalty payable font style margin font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size certain information this page nbsp been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size chimerix respect such product such country subsequent calendar quarter until full deduction taken provided however that event shall royalty otherwise owed contravir chimerix calendar quarter such country reduced more than result such offset aggregate clarity event shall contravir entitled deduct from royalty payable chimerix hereunder royalty other amount that paid payable contravir third party with respect patent right other intellectual property right covering other active combination product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold compulsory license font font size style font size compulsory license granted third party with respect product country with royalty rate lower than royalty rate under section nbsp then royalty rate applicable sale such product that country under section nbsp shall reduced rate which percentage point nbsp basis point than rate paid compulsory licensee provided however that royalty rate payable compulsory licensee with respect sale such product such country then contravir shall chimerix royalty received contravir affiliate with respect sale such product such country such compulsory licensee font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold adjustment generic competition font font size style font size product product country country basis during portion royalty term product country when valid patent claim chimerix patent right cover manufacture sale such product such country there regulatory exclusivity such product such country more generic version such product account more aggregate unit sale such product such generic version nbsp such country calendar quarter determined reference applicable sale data obtained from health from such other source such sale data agreed upon party provided that such other source shall generally recognized reliable source pharmaceutical sale data among major pharmaceutical company then remainder royalty term such product such country royalty payable contravir under section nbsp with respect sale such product such country shall reduced font style margin text indent font size face time roman style font size nbsp font style margin size width noshade color black align left style margin font size face time roman style font size certain information this page nbsp been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir board director observer right font font size style font size until earlier nbsp term this agreement nbsp when chimerix hold than preferred stock common stock issued upon conversion preferred stock contravir shall invite representative chimerix reasonably acceptable contravir style font weight bold representative attend meeting board director committee thereof voting observer capacity this respect shall give such representative copy notice minute consent other material that provides board director committee thereof provided however nbsp that contravir reserve right withhold information exclude such representative from meeting portion thereof reasonably determined chairman board majority member board director necessary protect confidentiality information avoid material conflict interest preserve attorney client privilege nbsp that event shall failure provide notice described above invalidate action taken meeting board director committee thereof initial representative shall michael rogers font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold payment record audit font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold payment report font font size style font size font font size style font size oyalties under section nbsp shall calculated reported each calendar quarter during royalty term shall paid within nbsp after calendar quarter each payment royalty shall accompanied report sale product contravir related party sufficient detail permit confirmation accuracy payment made including gross sale sale product product product country country basis including calculation sale combination product pursuant section nbsp based active ingredient such combination product deduction from gross sale major category forth definition sale detail royalty credit taken pursuant section nbsp nbsp third party patent license third party patent license basis applicable reduction adjustment made pursuant section nbsp section nbsp royalty payable exchange rate used font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold exchange rate manner place payment font font size style font size payment amount this agreement expressed dollar payment hereunder shall payable dollar when conversion payment from foreign currency required such conversion shall calculated using exchange rate equal average interbank rate exchange such currency reported oanda during calendar quarter which payment payment owed under this agreement shall made wire transfer immediately available fund bank account designated writing chimerix font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold income withholding font font size style font size chimerix will levied account payment made under this agreement required withheld contravir from payment made chimerix under this agreement contravir shall nbsp deduct such from payment made chimerix nbsp timely proper taxing authority nbsp send proof payment chimerix certify receipt taxing authority within nbsp following such payment nbsp cooperate with chimerix reasonably font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size requested chimerix obtain available reduction credit refund such font font size style font size without limiting generality foregoing font font size style font size request chimerix contravir shall provide chimerix such information contravir possession reasonably necessary chimerix obtain benefit present future treaty against double taxation which apply payment made chimerix under this agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size contravir required make payment chimerix subject deduction withholding such deduction withholding obligation arises solely result assignment this agreement contravir result failure part contravir comply with applicable relating withholding each case after effective date that effect increasing deduction withholding such payment above amount deduction withholding that would otherwise deducted withheld prior such assignment this agreement prior such failure contravir comply with such applicable applicable style font weight bold contravir withholding action then payment contravir respect which such deduction withholding required made shall increased amount such additional deduction withholding style font weight bold additional solely extent that nbsp such additional arises solely direct result such contravir withholding action nbsp such additional recovered chimerix additional along with other deducted withheld from payment made contravir shall timely remitted proper governmental authority account chimerix accordance with applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold audit font font size style font size contravir shall keep shall cause affiliate sublicensees keep complete accurate record pertaining sale other disposition product sufficient detail permit chimerix confirm accuracy royalty payment hereunder least five nbsp full calendar year following calendar year which they pertain chimerix shall have right once annually cause independent certified public accountant reasonably acceptable contravir audit such record solely confirm sale royalty period covering more than preceding five nbsp full calendar year calendar year shall subject audit under this section more than once such audit exercised during normal business hour upon reasonable prior written notice than contravir location where record maintained auditor will execute reasonable written confidentiality agreement with contravir will disclose chimerix only such information reasonably necessary provide chimerix with information regarding actual potential discrepancy between amount reported actually paid amount payable under this agreement auditor will send copy report contravir same time sent chimerix report sent both party will include methodology calculation used determine result prompt adjustment shall made party reflect result such audit chimerix shall bear full cost such audit unless such audit discloses underpayment contravir more than amount calendar year under this agreement which case contravir shall bear full cost such audit shall promptly remit chimerix amount underpayment such audit discloses overpayment contravir then contravir will deduct amount such overpayment from amount otherwise owed chimerix under this agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold late payment font font size style font size event that payment under this agreement made when payment shall accrue interest rate annum that nbsp basis point four percentage point above font font size style font size then current font font size style font size prime font font size style font size rate quoted citibank york city font font size style font size period from date payment until date actual payment provided however that event shall such rate exceed maximum legal annual interest rate payment such interest shall limit chimerix from exercising other right have consequence lateness payment font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold confidentiality publication font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold confidential information font font size style font size except extent expressly authorized this agreement each party such capacity style font weight bold receiving party agrees that during term nbsp year thereafter shall keep confidential shall publish otherwise disclose third party shall purpose other than expressly provided this agreement other written agreement between party confidential information furnished made available behalf other party such capacity style font weight bold disclosing party receiving party shall least same standard care protect proprietary confidential information event than reasonable care ensure that affiliate employee agent consultant other representative disclose make unauthorized confidential information receiving party shall promptly notify disclosing party upon discovery unauthorized disclosure disclosing party confidential information font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold exception font font size style font size confidential information shall include information which receiving party prove competent evidence nbsp hereafter becomes through failure part receiving party generally known available nbsp known receiving party affiliate time receiving such information evidenced record nbsp hereafter furnished receiving party affiliate third party matter right without restriction disclosure nbsp independently discovered developed receiving party affiliate without confidential information disclosing party combination feature disclosure shall deemed fall within exclusion forth preceding clause nbsp nbsp nbsp merely because individual feature published available general public rightful possession receiving party unless combination itself principle operation published available general public rightful possession receiving party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold authorized disclosure font font size style font size notwithstanding provision section nbsp receiving party disclose confidential information disclosing party expressly permitted this agreement extent such disclosure reasonably necessary following instance font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size filing prosecuting patent permitted this agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size enforcing such party right under this agreement performing obligation under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size prosecuting defending litigation permitted this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size complying with applicable court order applicable rule nbsp regulation listing rule nbsp exchange which receiving party security traded font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size disclosure affiliate actual potential licensee sublicensees employee consultant agent receiving party have need know such information order receiving party exercise right fulfill obligation under this agreement provided each case that such affiliate actual potential licensee sublicensee employee consultant agent agrees bound term confidentiality comparable scope those forth this article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size case chimerix disclosure extent required comply with license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size disclosure third party connection with diligence similar investigation such third party disclosure potential third party investor confidential financing document provided each case that such third party agrees bound reasonable obligation confidentiality font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding foregoing event receiving party required make disclosure disclosing party confidential information pursuant section nbsp nbsp will except where impracticable give reasonable advance notice disclosing party such disclosure effort secure confidential treatment such information least diligent receiving party would protect confidential information event than reasonable effort event receiving party agrees take reasonable action avoid disclosure confidential information hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold publication font font size style font size contravir affiliate shall have right publish result their development activity including clinical trial with respect compound product field chimerix shall have right review comment material proposed disclosure publication contravir affiliate such oral presentation manuscript abstract that relates development manufacture commercialization compound product that includes confidential information chimerix before such material submitted publication disclosure other than oral presentation material abstract which addressed below contravir shall deliver complete copy chimerix least nbsp prior submitting material publisher initiating such other disclosure chimerix shall review such material give comment contravir within nbsp delivery such material chimerix which comment shall considered contravir good faith with respect oral presentation material abstract contravir shall deliver complete copy chimerix least nbsp prior anticipated date presentation chimerix shall make reasonable effort expedite review such material abstract font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size shall return such item soon practicable contravir with appropriate comment event later than nbsp from date delivery chimerix which comment shall considered contravir good faith contravir shall comply cause affiliate comply applicable with chimerix request delete reference chimerix confidential information such material agrees delay submission publication other public disclosure period additional nbsp purpose preparing filing appropriate patent application addition contravir shall comply with chimerix request delete from such material unpublished chemical structure compound unpublished method synthesis compound chimerix shall publish information relating compound product field without prior written consent contravir such consent unreasonably withheld delayed provided however that notwithstanding foregoing other provision this agreement contrary chimerix academic collaborator nbsp shall free publish result research development activity with respect chimerix product whether conducted before after effective date provided that such publication refer disclose confidential information contravir extent practicable under circumstance extent chimerix right ability chimerix shall reasonable effort provide contravir with opportunity review comment proposed publication result research development activity with respect chimerix product shall comply with contravir request delete reference contravir confidential information provided however that failure provide contravir with opportunity review comment such proposed publication academic collaborator chimerix even more chimerix employee named author such publication chimerix contribution such research development acknowledged such publication which contain refer confidential information contravir will constitute breach chimerix obligation under this sentence such academic collaborator right contract institutional policy otherwise make such publication font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold publicity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold press release font font size style font size later than nbsp business following effective date party shall issue joint press release announcing execution this agreement substantially form attached hereto exhibit nbsp font font size style font size except required applicable security listing rule nbsp stock exchange which security issued party affiliate traded neither party shall make other public announcement concerning this agreement subject matter hereof without prior written consent other which shall unreasonably withheld delayed font font size style font size provided that each party make public statement response question press analyst investor those attending industry conference financial analyst call respond query exchange which such party security traded issue press release long such public statement response press release inconsistent with prior public disclosure public statement made accordance with this section nbsp which reveal public information about other party font font size style font size event required public announcement extent practicable under circumstance party making such announcement shall reasonable effort provide other party with copy proposed text such announcement sufficiently advance font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size scheduled release afford such other party reasonable opportunity review comment upon proposed text unless proposed text substantially same that used font font size style font size prior public disclosure press release public statement made accordance with this section nbsp font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold filing this agreement font font size style font size party shall coordinate advance with each other connection with filing this agreement including redaction certain provision this agreement with security authority with stock exchange which security issued party affiliate traded each party will reasonable effort seek confidential treatment term proposed redacted provided that each party will ultimately retain control over what information disclose security authority stock exchange case provided further that party will their reasonable effort file redacted version with governing body which consistent with redacted version previously filed with other governing body other than such obligation neither party affiliate will obligated consult with obtain approval from other party with respect filing security authority stock exchange font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold prior disclosure agreement font font size style font size effective date term this article nbsp shall supersede prior disclosure secrecy confidentiality agreement between party their affiliate dealing with subject this agreement including mutual disclosure agreement between party dated june nbsp information disclosed party pursuant such prior agreement shall deemed confidential information such party purpose this agreement font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold representation warranty certain covenant font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold mutual representation warranty font font size style font size each party represents warrant other that effective date nbsp duly organized validly existing under jurisdiction incorporation formation full corporate other power authority enter into this agreement carry provision hereof nbsp duly authorized execute deliver this agreement perform obligation hereunder person person executing this agreement behalf been duly authorized requisite corporate partnership action nbsp this agreement legally binding upon enforceable accordance with term conflict with agreement instrument understanding oral written which party which bound including with respect chimerix license violate material regulation court governmental body administrative other agency having jurisdiction over font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix representation warranty font font size style font size chimerix represents warrant contravir that effective date this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold exhibit nbsp font font size style font size attached hereto contains true complete list chimerix patent right existing effective date chimerix patent right listed exhibit nbsp include patent right controlled chimerix effective date that font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size cover compound compound controlled chimerix effective date that known converting compound manufacture sale offer sale import foregoing font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix nbsp right grant license that purport grant section nbsp nbsp granted third party license other right with respect compound product chimerix technology that conflict with license right granted contravir herein except that under term merck agreement license granted merck thereunder survive exclusive basis until august nbsp solely permit merck affiliate their respective sublicensees distributor finish product related manufacturing work process sell such product other product compound remaining inventory chimerix will amend extend license under merck agreement manner that would reasonably expected detrimentally affect contravir right under this agreement without express written consent contravir font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size other than license there agreement effect effective date between chimerix third party under which right with respect chimerix technology being licensed chimerix font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix sole exclusive owner right title interest chimerix patent right existence effective date other than chimerix patent right owner nbsp which identified exhibit nbsp which subject nbsp agreement sponsor right such term defined license nbsp reserved right under license nbsp dana farber cancer institute reserved right under license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size best chimerix knowledge issued unexpired claim included chimerix patent right existing effective date valid enforceable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size knowledge chimerix reexamination interference invalidity opposition nullity similar claim proceeding pending threatened with respect chimerix patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size knowledge chimerix manufacture using manufacturing process used behalf chimerix before effective date sale offer sale import infringe issued patent chimerix received written notice from third party claiming that manufacture sale offer sale import compound product infringes would infringe patent other intellectual property right third party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size there claim judgment settlement against owed chimerix affiliate with respect chimerix technology chimerix party legal action suit proceeding relating chimerix technology compound product chimerix received written communication from third font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size party including without limitation regulatory authority other government agency threatening such action suit proceeding font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size license legal valid enforceable full force effect chimerix nbsp provided contravir true complete copy license nbsp party license best chimerix knowledge material violation material default under there exist condition which upon passage time giving notice both would reasonably expected cause such material violation material default under permit termination modification acceleration license consent that already been obtained chimerix required connection with entry chimerix into this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size tangible recorded information data provided behalf chimerix contravir related compound product before effective date contemplation this agreement true accurate complete material respect chimerix failed disclose failed cause disclosed such information data related compound product possession control that would cause information data that been disclosed misleading material respect provided however that with respect such information data related compound product that generated behalf merck style font weight bold merck data chimerix represents warrant style font style italic only that nbsp chimerix made available true complete copy tangible recorded embodiment such merck data that were provided chimerix merck nbsp chimerix actual knowledge material merck data that merck failed disclose chimerix that merck data that provided chimerix merck materially false inaccurate except forth preceding clause nbsp nbsp merck data provided contravir basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size neither chimerix affiliate obtained filed inds other than compound ndas marketing approval compound product field best chimerix knowledge other person obtained filed inds ndas marketing approval compound product field territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size time delivery contravir inventory will free clear lien encumbrance except preceding representation warranty inventory provided nbsp where nbsp basis without representation warranty kind without limiting generality foregoing chimerix make representation warranty that inventory nbsp conforms applicable specification nbsp manufactured compliance with nbsp adulterated misbranded within meaning font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size there ongoing research development activity including clinical trial being conducted behalf chimerix affiliate with respect compound product field territory avoidance doubt however contravir acknowledges that chimerix academic collaborator nbsp conducting having conducted research development activity including clinical trial with respect chimerix product font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size nbsp research development including clinical study clinical trial conducted behalf chimerix affiliate related compound product prior effective date conducted compliance material respect with applicable applicable nbsp chimerix knowledge research development including clinical study clinical trial conducted behalf merck affiliate related compound product prior effective date conducted compliance material respect with applicable applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size neither chimerix affiliate debarred disqualified under comparable applicable outside united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size neither chimerix affiliate employed otherwise used capacity connection with development manufacture compound product service person debarred disqualified under united state including foreign equivalent thereof provided however that chimerix make such representation warranty regarding person employed used merck affiliate connection with development manufacture compound product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix best knowledge director officer employee agent representative subcontractor other third party acting such behalf directly indirectly offered paid promised authorized such offer promise payment anything value person purpose obtaining retaining business through improper advantage connection with development commercialization exploitation product that would otherwise violate applicable rule nbsp regulation concerning relating public commercial bribery corruption chimerix book account record invoice related product complete accurate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix knowledge violated fcpa export control connection with development compound prior effective date this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix covenant font font size style font size addition covenant made chimerix elsewhere this agreement chimerix hereby covenant contravir follows font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size during term chimerix will grant third party license other right with respect compound product chimerix technology derogation license right granted contravir hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix shall maintain license full force effect shall terminate license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix shall amend waive take action omit take action that would alter chimerix right under license manner that font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size adversely affect would reasonably expected adversely affect contravir right under this agreement font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix shall promptly notify contravir receipt delivery notice default under termination amendment agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir representation warranty font font size style font size contravir represents warrant chimerix that effective date this agreement neither contravir affiliate debarred disqualified under comparable applicable outside united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir covenant font font size style font size addition covenant made contravir elsewhere this agreement contravir hereby covenant chimerix follows font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size neither contravir affiliate will employ service person debarred disqualified under united state including foreign equivalent thereof connection with activity relating compound product event that contravir becomes aware debarment disqualification threatened debarment disqualification person providing service contravir affiliate with respect activity relating compound product contravir will immediately notify chimerix writing contravir will cease cause affiliate cease applicable employing contracting with retaining such person perform service relating compound product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size neither contravir affiliate will connection with exercise right performance obligation under this agreement directly indirectly through third party promise offer authorize payment money give promise offer give authorize giving anything value public official entity other person purpose obtaining retaining business with directing business person including contravir affiliate will contravir affiliate directly indirectly promise offer provide corrupt payment gratuity emolument bribe kickback illicit gift hospitality other illegal unethical benefit public official entity other person connection with exercise contravir right performance contravir obligation under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size neither contravir affiliate their respective employee contractor connection with exercise contravir right performance contravir obligation under this agreement shall cause chimerix violation fcpa export control font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size contravir shall immediately notify chimerix information suspicion that there violation fcpa export control connection with exercise contravir right performance contravir obligation under this agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold performance affiliate sublicensees subcontractor font font size style font size party recognize that each party perform some obligation exercise some right under this agreement through more affiliate subcontractor case contravir subject section nbsp sublicensees provided each case that nbsp none other party right hereunder diminished otherwise adversely affected result such delegation subcontracting nbsp each such affiliate subcontractor sublicensee undertakes writing obligation confidentiality regarding confidential information ownership invention which substantially same those undertaken party pursuant article nbsp section nbsp provided further that such party shall time fully responsible performance payment such affiliate subcontractor sublicensee font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold disclaimer font font size style font size except expressly forth this agreement technology intellectual property right provided each party hereunder provided except expressly forth this agreement each party expressly disclaims warranty kind express implied nbsp including without limitation warranty design merchantability fitness particular purpose validity patent infringement intellectual property right third party arising from course dealing usage trade practice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold limitation liability font font size style font size except liability breach article nbsp case fraud intentional misconduct neither party shall entitled recover from other party special nbsp incidental consequential punitive damage connection with this agreement license granted hereunder provided however that this section nbsp shall construed limit either party indemnification obligation under article nbsp font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold intellectual property font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold ownership font font size style font size between party chimerix shall time sole exclusive owner right title interest chimerix technology other than joint invention joint patent right contravir shall time sole exclusive owner right title interest contravir technology other than joint invention joint patent right party shall have retain right title interest invention made solely more employee agent such party affiliate other person acting under authority font font size style font size party shall jointly right invention made jointly more employee agent each party affiliate other person acting under authority joint invention patent right therein joint patent right font font size style font size subject right license granted under this agreement each party shall have right practice grant license practice joint font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size invention joint patent right without other party consent duty account other party such practice license each party hereby waif right have under country require such consent accounting font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent prosecution maintenance font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix patent right font font size style font size right obligation party forth this section nbsp nbsp shall subject right under license with respect chimerix patent right controlled chimerix through license style font weight bold chimerix patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix only patent right font font size style font size chimerix shall have sole right obligation control preparation filing prosecution maintenance chimerix patent right that claim cover compound product then being developed commercialized behalf contravir related party field such chimerix patent right style font weight bold chimerix only patent right chimerix sole expense counsel choice provided however that nbsp chimerix patent right shall considered chimerix only patent right only during period when compound product being developed commercialized behalf contravir related party field claimed covered such chimerix patent right nbsp upon contravir related party commencing development commercialization compound product claimed covered such chimerix patent right field long thereafter contravir related party continues developing commercializing such compound product field such chimerix patent right shall deemed chimerix overlapping patent right shall subject section nbsp nbsp instead this section nbsp avoidance doubt chimerix patent that cover shall considered chimerix only patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix overlapping patent right font font size style font size chimerix shall have sole except expressly forth below right obligation control preparation filing prosecution maintenance chimerix patent right that claim cover both nbsp chimerix product compound that compound product that product that each case being developed commercialized behalf chimerix affiliate licensee academic collaborator nbsp compound product then being developed commercialized behalf contravir related party field such chimerix patent right style font weight bold chimerix overlapping patent right collectively with chimerix only patent right style font weight bold chimerix restricted patent right chimerix sole expense counsel choice provided however that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix patent right shall considered chimerix overlapping patent right only during period when claim cover both compound product described clause nbsp nbsp initial paragraph this section nbsp nbsp compound product being developed commercialized behalf contravir related party field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size upon chimerix including purpose this clause nbsp nbsp only affiliate licensee academic collaborator ceasing font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size development commercialization compound product described clause nbsp nbsp initial paragraph this section nbsp nbsp that claimed covered such chimerix patent right long thereafter both nbsp chimerix developing commercializing such compound product nbsp contravir related party developing commercializing field compound product claimed covered such chimerix patent right such chimerix patent right shall deemed chimerix other patent right shall subject section nbsp nbsp instead this section nbsp font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size upon contravir including related party ceasing development commercialization field compound product claimed covered such chimerix patent right long thereafter contravir including related party developing commercializing such compound product field such chimerix patent right shall deemed chimerix only patent right shall subject section nbsp nbsp instead this section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size chimerix shall consult with contravir preparation filing prosecution maintenance chimerix overlapping patent right reasonably prior deadline action with patent office shall furnish contravir copy relevant draft document reasonably advance such consultation chimerix shall keep contravir reasonably informed progress with regard preparation filing prosecution maintenance chimerix overlapping patent right shall provide contravir copy material patent office submission within reasonable amount time following submission thereof chimerix chimerix shall consider comment contravir good faith event that chimerix desire abandon cease prosecution maintenance chimerix overlapping patent right chimerix shall provide written notice contravir such intention abandon promptly after chimerix make such determination which notice shall given later than nbsp prior next deadline action that must taken with respect such chimerix overlapping patent right relevant patent office such case upon receipt written request contravir assume responsibility prosecution maintenance such chimerix overlapping patent right chimerix shall allow contravir sole cost expense counsel choice delivered later than nbsp after receipt notice from chimerix assume such responsibility font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix other patent right font font size style font size chimerix shall have first right obligation control preparation filing prosecution maintenance chimerix patent right that chimerix restricted patent right style font weight bold chimerix other patent right chimerix sole expense counsel choice chimerix shall consult with contravir preparation filing prosecution maintenance chimerix other patent right reasonably prior deadline action with patent office shall furnish contravir copy relevant draft document reasonably advance such consultation chimerix shall keep contravir reasonably informed progress with regard preparation filing prosecution maintenance chimerix other patent right shall provide contravir copy material patent office submission within reasonable amount time following submission thereof chimerix event that chimerix desire abandon cease prosecution maintenance chimerix other patent right chimerix font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size shall provide written notice contravir such intention abandon promptly after chimerix make such determination which notice shall given later than nbsp prior next deadline action that must taken with respect such chimerix other patent right relevant patent office such case contravir shall have right discretion exercisable upon written notice chimerix delivered later than nbsp after receipt notice from chimerix assume responsibility prosecution maintenance such chimerix other patent right sole cost expense counsel choice contravir exercise such right then chimerix shall assign contravir chimerix right title interest such chimerix other patent right provided that contravir shall hereby grant chimerix exclusive worldwide royalty free fully paid irrevocable perpetual license including right sublicense through multiple tier sublicense under such chimerix other patent right solely discover develop make have made sell have sold offer sale market import export otherwise commercialize nbsp chimerix product nbsp compound that compound product containing compound that compound containing compound including without limitation brincidofovir font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint patent right font font size style font size contravir shall have first right obligation prepare file prosecute maintain joint patent right contravir sole expense counsel selected contravir reasonably acceptable chimerix contravir shall consult with chimerix preparation filing prosecution maintenance joint patent right reasonably prior deadline action with patent office shall furnish chimerix copy relevant draft document reasonably advance such consultation contravir shall keep chimerix reasonably informed progress with regard preparation filing prosecution maintenance joint patent right shall provide chimerix copy material patent office submission within reasonable amount time following submission thereof contravir event that contravir desire abandon cease prosecution maintenance joint patent right contravir shall provide written notice chimerix such intention abandon promptly after contravir make such determination which notice shall given later than nbsp prior next deadline action that must taken with respect such joint patent right relevant patent office such case chimerix shall have right discretion exercisable upon written notice contravir delivered later than nbsp after receipt notice from contravir assume responsibility prosecution maintenance such joint patent right sole cost expense counsel choice chimerix exercise such right then contravir shall cease have license under chimerix joint ownership interest such joint patent right shall retain contravir joint ownership interest such joint patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir patent right font font size style font size contravir shall have sole right obligation control preparation filing prosecution maintenance contravir patent right contravir sole expense counsel choice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cooperation party font font size style font size each party agrees cooperate fully preparation filing prosecution maintenance patent right under this agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size obtaining maintenance patent extension supplementary protection certificate like with respect patent right such cooperation includes limited nbsp executing paper instrument requiring employee contractor execute such paper instrument effectuate joint ownership joint invention joint patent right forth section nbsp enable other party apply prosecute patent application country accordance with foregoing provision this section nbsp nbsp promptly informing other party matter coming such party attention that affect preparation filing prosecution maintenance such patent application font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold interference opposition nbsp invalidation reexamination reissue font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix patent right font font size style font size right obligation party forth this section nbsp nbsp shall subject right under license with respect chimerix patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold relevant chimerix patent claim font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix first right font font size style font size chimerix shall within nbsp learning such event inform contravir request filing declaration interference opposition invalidation reissue reexamination relating claim chimerix overlapping patent right chimerix other patent right that cover compound manufacture style font weight bold relevant chimerix patent claim with respect request filing declaration interference opposition invalidation reissue reexamination relating relevant chimerix patent claim chimerix shall have first right discretion initiate prosecute respond such action proceeding provided that chimerix shall consult with contravir with respect such action proceeding shall consider contravir position good faith event that chimerix elect initiate prosecute respond interference opposition invalidation reexamination reissue proceeding relating relevant chimerix patent claim expense thereof shall borne solely chimerix chimerix shall settle interference opposition invalidation reissue reexamination action proceeding relating relevant chimerix patent claim without prior written consent contravir which consent shall unreasonably withheld chimerix shall keep contravir informed development such action proceeding involving relevant chimerix patent claim font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir back right font font size style font size chimerix shall promptly inform contravir event that chimerix elect initiate prosecute respond interference opposition invalidation reissue reexamination relating relevant chimerix patent claim such case contravir shall have right contravir discretion cost expense contravir shall settle interference opposition invalidation reissue reexamination action proceeding relating relevant chimerix patent claim without prior written consent chimerix which consent shall unreasonably withheld contravir shall keep chimerix informed development such action proceeding involving relevant chimerix patent claim font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold other chimerix patent claim font font size style font size chimerix shall have sole right discretion handle interference opposition invalidation reissue reexamination proceeding relating nbsp claim chimerix overlapping patent right chimerix other patent right that style font style italic relevant chimerix patent claim nbsp claim chimerix only patent right collectively style font weight bold other chimerix patent claim each case contravir shall have right connection therewith provided however that event time such interference opposition invalidation reissue reexamination proceeding applicable other chimerix patent claim contained chimerix other patent right that been assigned being prosecuted maintained contravir pursuant section nbsp then such instance contravir shall have sole right continue handle such matter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint patent right font font size style font size each party shall within nbsp learning such event inform other party request filing declaration interference opposition invalidation reissue reexamination relating joint patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold relevant joint patent claim font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir first right font font size style font size with respect request filing declaration interference opposition invalidation reissue reexamination relating claim joint patent right that cover compound manufacture style font weight bold relevant joint patent claim contravir shall have first right discretion initiate prosecute respond such action proceeding provided that contravir shall consult with chimerix with respect such action proceeding shall take into consideration whether such relevant joint patent claim also cover chimerix product shall consider chimerix position good faith event that contravir elect initiate prosecute respond interference opposition invalidation reexamination reissue proceeding relating relevant joint patent claim expense thereof shall borne solely contravir contravir shall settle interference opposition invalidation reissue reexamination action proceeding relating relevant joint patent claim without prior written consent chimerix which consent shall unreasonably withheld contravir shall keep chimerix informed development such action proceeding involving relevant joint patent claim font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix back right font font size style font size contravir shall promptly inform chimerix event that contravir elect initiate prosecute respond interference opposition invalidation reissue reexamination relating relevant joint patent claim such case chimerix shall have right chimerix discretion cost expense chimerix shall settle interference opposition invalidation reissue reexamination action proceeding relating relevant joint patent claim without prior written consent contravir which consent shall unreasonably withheld chimerix shall keep contravir informed development such action proceeding involving relevant joint patent claim font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold other joint patent claim font font size style font size party shall mutually agree case case basis which party will have right handle interference opposition font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size invalidation reissue reexamination proceeding relating claim joint patent right that style font style italic relevant joint patent claim style font weight bold other joint patent claim expense such action proceeding will allocated neither party shall settle interference opposition invalidation reissue reexamination action proceeding relating other joint patent claim without prior written consent other party which consent shall unreasonably withheld party handling such action proceeding shall keep other party informed development such action proceeding involving other joint patent claim font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir patent right font font size style font size contravir shall have sole right discretion handle interference opposition invalidation reissue reexamination proceeding relating contravir patent right chimerix shall have right connection therewith font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold enforcement defense patent right font font size style font size each party shall notify other party writing within nbsp business except expressly forth below becoming aware alleged threatened infringement third party chimerix patent right joint patent right contravir patent right style font weight bold infringement including nbsp such alleged threatened infringement account third party manufacture sale compound product field nbsp certification filed united state under nbsp nbsp similar provision other jurisdiction connection with anda abbreviated drug application united state comparable application marketing approval under applicable country other than united state other product field style font weight bold patent certification nbsp declaratory judgment action filed third party that developing manufacturing commercializing compound product field alleging invalidity unenforceability infringement chimerix patent right joint patent right contravir patent right collectively style font weight bold contravir competitive infringement provided however that each party shall notify other party patent certification regarding chimerix patent right joint patent right that receives such party shall provide other party with copy such patent certification within five nbsp receipt except that contravir receives patent certification with respect chimerix patent right contravir shall provide such notice copy chimerix within nbsp receipt order permit chimerix comply with notification obligation under license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix patent right font font size style font size right obligation party forth this section nbsp nbsp shall subject right under license with respect chimerix patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir competitive infringement font font size style font size contravir shall have first right obligation bring defend control action proceeding with respect contravir competitive infringement chimerix patent right contravir expense counsel choice chimerix shall have right represented such action proceeding chimerix expense counsel choice contravir fails bring such action proceeding with respect contravir competitive font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size infringement chimerix patent right within nbsp following notice alleged contravir competitive infringement chimerix shall have right bring defend control such action expense counsel choice contravir shall have right expense represented such action counsel choice provided however that applicable contravir competitive infringement result contravir receipt patent certification with respect chimerix patent right contravir shall notify chimerix contravir decision bring defend control action proceeding within nbsp nbsp contravir receipt such patent certification with respect chimerix patent right other than chimerix patent right nbsp five nbsp contravir receipt such patent certification with respect chimerix patent right after which time each case chimerix shall have right bring defend prosecute such action contravir shall have right expense represented such action counsel choice font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold other infringement font font size style font size chimerix shall have sole right obligation bring defend control action proceeding with respect infringement chimerix patent right that contravir competitive infringement expense counsel choice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir competitive infringement font font size style font size contravir shall have first right obligation bring defend control action proceeding with respect contravir competitive infringement joint patent right expense counsel choice chimerix shall have right expense represented such action counsel choice contravir fails bring such action proceeding with respect contravir competitive infringement joint patent right within nbsp following notice alleged infringement chimerix shall have right bring defend control such action expense counsel choice contravir shall have right expense represented such action counsel choice provided however that applicable contravir competitive infringement result contravir receipt patent certification with respect joint patent right contravir shall notify chimerix contravir decision bring defend control action proceeding within nbsp contravir receipt such patent certification with respect joint patent right after which time chimerix shall have right bring defend prosecute such action contravir shall have right expense represented such action counsel choice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix competitive infringement font font size style font size chimerix shall have first right obligation bring defend control action proceeding with respect infringement joint patent right extent infringement competitive with chimerix product being developed commercialized chimerix affiliate licensee sublicensees style font weight bold chimerix competitive infringement expense counsel choice contravir shall have right expense represented such action counsel choice chimerix fails bring such font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size action proceeding with respect chimerix competitive infringement joint patent right within nbsp following notice alleged infringement contravir shall have right bring defend control such action expense counsel choice chimerix shall have right expense represented such action counsel choice provided however that applicable chimerix competitive infringement result chimerix receipt patent certification with respect joint patent right chimerix shall notify contravir chimerix decision bring defend control action proceeding within nbsp chimerix receipt such patent certification with respect chimerix patent right after which time chimerix shall have right bring defend prosecute such action contravir shall have right expense represented such action counsel choice font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold other infringement font font size style font size party shall mutually agree case case basis nbsp whether bring defend control action proceeding with respect infringement joint patent right extent infringement neither contravir competitive infringement chimerix competitive infringement nbsp which party would bring defend control such action nbsp expense recovery from such action would allocated font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir patent right font font size style font size contravir shall have sole right obligation bring defend control action proceeding with respect infringement contravir patent right expense counsel choice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cooperation font font size style font size event party brings defends infringement action accordance with this section nbsp event party entitled bring defend infringement action accordance with this section nbsp lack standing other party shall cooperate fully including required bring defend such action furnishing power attorney being named party neither party shall enter into settlement compromise action under this section nbsp which would manner alter diminish derogation other party right under this agreement without prior written consent such other party which shall unreasonably withheld font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold recovery font font size style font size except otherwise agreed party connection with cost sharing arrangement recovery realized party result action proceeding pursuant this section nbsp whether settlement otherwise shall applied first reimburse documented pocket legal expense party that brought defended controlled such action proceeding incurred connection with such action proceeding second reimburse documented pocket legal expense other party incurred connection with such action proceeding remaining amount shall retained party that brought defended controlled such action provided however that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size recovery realized contravir result action brought defended controlled contravir pursuant section nbsp nbsp section nbsp nbsp after reimbursement party documented pocket legal expense font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size relating action proceeding shall allocated follows subject payment required license font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size compensatory damage shall awarded treated sale product quarter which such damage received purpose section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size compensatory damage shall divided contravir chimerix font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size recovery realized chimerix result action brought controlled chimerix pursuant section nbsp nbsp after reimbursement party documented pocket legal expense relating action proceeding shall allocated follows subject payment required license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size compensatory damage shall belong solely chimerix font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size compensatory damage shall shared equally party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold patent term extension font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold chimerix patent right font font size style font size right obligation party forth this section nbsp nbsp shall subject right under license with respect chimerix patent right contravir shall have right determine chimerix patent right which will apply patent extension country region product field style font style italic other than chimerix patent right country region which chimerix affiliate licensee sublicensee already applied received patent extension nbsp chimerix product nbsp compound that compound product that product including without limitation brincidofovir contravir shall file such extension contravir cost expense chimerix shall provide reasonable assistance contravir connection with such filing provided that contravir shall reimburse pocket cost incurred chimerix providing such assistance font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold joint patent right font font size style font size contravir shall have right determine joint patent right which will apply patent extension country region product field contravir shall file such extension contravir cost expense provided however that solely case joint patent right that claim cover product field chimerix shall have right determine those such joint patent right which will apply patent extension country region chimerix product chimerix shall file such extension chimerix cost expense each party shall provide reasonable assistance other party connection with such filing provided that party filing such extension shall reimburse pocket cost incurred other party providing such assistance font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold contravir patent right font font size style font size contravir shall have sole right apply extension contravir patent right country region product including without limitation product field contravir sole cost expense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold infringement third party right font font size style font size each party shall promptly notify other writing allegation third party that activity either party pursuant this agreement infringes infringe intellectual property right such third party neither party shall have right settle patent infringement litigation under this section nbsp manner that diminishes right interest other party without written consent such other party which shall unreasonably withheld font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold license font font size style font size extent right contravir under this article nbsp subject term license with respect chimerix patent right chimerix agrees reasonable effort facilitate interaction between contravir allow contravir exercise right forth this article nbsp chimerix agrees reasonably consult cooperate with contravir connection therewith font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold marking font font size style font size extent required applicable contravir shall shall cause related party mark product made used sold field their container with number each issued chimerix patent right that applies such product provided however that event contravir shall shall cause related party mark product made used sold field their container with number each issued chimerix patent right that applies such product font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold term termination font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold term font font size style font size term this agreement shall commence effective date unless earlier terminated accordance with this article nbsp continue until expiration last expire royalty payment obligation contravir hereunder style font weight bold term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold termination material breach font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size each party shall have right terminate this agreement entirety upon written notice other party such other party material breach this agreement cured such breach within nbsp nbsp with respect payment breach after notice from terminating party requesting cure breach such termination shall become effective such with respect payment breach period unless breaching party cured such breach prior such period right terminate under this section nbsp nbsp shall stayed cure period tolled event that during cure period party alleged have been material breach shall have initiated dispute resolution accordance with article nbsp with respect alleged breach which stay tolling shall continue until such dispute been resolved accordance with article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size clarity event material breach this agreement chimerix that cured within applicable notice period forth section nbsp contravir sole discretion either font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size terminate this agreement accordance with section nbsp nbsp addition pursuing remedy that available contravir equity result chimerix breach this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size elect nbsp terminate this agreement nbsp retain license granted under section nbsp subject term condition hereof nbsp pursue remedy that available contravir equity result chimerix breach this agreement without prejudice contravir right terminate this agreement later date pursuant section nbsp that uncured material breach other uncured material breach this agreement chimerix pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold termination patent challenge font font size style font size chimerix shall have right terminate this agreement immediately upon written notice contravir contravir affiliate directly through assistance granted third party commences interference opposition proceeding with respect challenge validity enforceability opposes extension grant supplementary protection certificate with respect chimerix patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold will termination contravir font font size style font size contravir shall have right terminate this agreement country country basis reason reason time upon nbsp prior written notice chimerix font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold effect expiration termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold expiration font font size style font size upon expiration earlier termination this agreement license granted chimerix contravir that were effect immediately prior such expiration shall survive exclusive fully paid royalty free basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold termination font font size style font size upon termination this agreement prior expiration license country country basis event partial termination contravir under section nbsp granted contravir pursuant section nbsp shall automatically terminate revert chimerix other right obligation party under this agreement shall terminate except expressly provided below this section nbsp elsewhere this article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold termination chimerix pursuant section nbsp contravir pursuant section nbsp font font size style font size solely event termination this agreement chimerix pursuant section nbsp section nbsp contravir pursuant section nbsp following provision shall apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size effective such termination contravir shall hereby grant chimerix nbsp exclusive worldwide royalty free fully paid perpetual font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size irrevocable license with right sublicense through multiple tier sublicense under those contravir patent right that claim invention made solely more employee agent contravir affiliate course conducting research development manufacturing regulatory commercialization activity contemplated this agreement contravir know contravir interest joint patent right nbsp exclusive worldwide royalty free fully paid perpetual irrevocable license with right sublicense through multiple tier sublicense under blocking patent defined below each case solely develop make have made sell offer sale import compound product field purpose this section nbsp style font weight bold blocking patent shall mean contravir patent right style font style italic other than those described clause nbsp nbsp this section nbsp excluding such contravir patent right claiming manufacturing formulation technology that actually used contravir related party prior termination development manufacture commercialization compound product field notwithstanding foregoing extent blocking patent include patent right licensed contravir third party other than sublicensee that subject royalty milestone payment obligation such third party with respect compound product then contravir shall notify chimerix together with true complete correct description such royalty milestone payment obligation inclusion such blocking patent license granted chimerix under clause nbsp nbsp this section nbsp nbsp shall subject chimerix agreeing writing reimburse promptly reimbursing contravir royalty milestone payment that become such third party reason chimerix exercise blocking patent development manufacture commercialization compound product field font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size promptly practicable event within nbsp after such termination contravir shall nbsp extent previously provided chimerix deliver chimerix true correct complete copy regulatory document disclose chimerix previously undisclosed contravir know nbsp transfer assign cause transferred assigned chimerix designee extent assignable take reasonable action make available chimerix designee benefit inds ndas marketing approval product whether held name contravir related party nbsp take such other action execute such other instrument assignment document necessary effect evidence register record transfer assignment other conveyance right under this this section nbsp nbsp chimerix font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size contravir shall directed chimerix either promptly wind down ongoing development activity with respect product orderly fashion promptly transition such development activity chimerix designee with regard patient safety compliance with applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size chimerix shall have right obligation purchase from contravir usable inventory compound product contravir affiliate possession date termination such inventory shall provided transfer price equal contravir cost such inventory font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size contravir prior termination manufacturing having manufactured behalf quantity compound product then chimerix request until earlier nbsp such time chimerix secured another source thereof that able meet chimerix quality quantity requirement nbsp nbsp month after such termination contravir shall commercially reasonable effort supply cause supplied chimerix such quantity thereof chimerix reasonably require development commercialization product field provided that chimerix shall commercially reasonable effort secure another source supply soon reasonably practicable such material shall provided transfer price equal contravir cost such material font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold accrued obligation survival font font size style font size neither expiration termination this agreement shall relieve either party obligation liability accruing prior such expiration termination shall expiration termination this agreement preclude either party from pursuing right remedy have under this agreement equity with respect breach this agreement addition party right obligation under section nbsp article this agreement shall survive expiration termination this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold return confidential information font font size style font size within nbsp following expiration termination this agreement except extent that party retains license from other party provided this article nbsp each party shall promptly return other party delete destroy relevant record material such party possession control containing confidential information other party provided that such party keep copy such material archival purpose only subject continuing confidentiality obligation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold damage relief font font size style font size termination this agreement shall preclude either party from claiming other damage compensation relief that entitled hereunder font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold indemnification font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold indemnification contravir font font size style font size contravir hereby agrees save defend indemnify hold harmless chimerix affiliate their respective officer director agent employee successor assigns style font weight bold chimerix indemnitees person specifically identified section nbsp nbsp license applicable indemnitees such term defined section nbsp nbsp license collectively style font weight bold license indemnitees from against loss damage liability expense cost including reasonable legal expense attorney style font weight bold loss which chimerix indemnitee license indemnitee become subject result claim demand action other proceeding third party each style font weight bold claim extent such loss arise relate nbsp gross negligence willful misconduct contravir indemnitee defined below nbsp breach contravir warranty representation covenant agreement made contravir this agreement nbsp development manufacture handling storage sale offer sale import other disposition behalf contravir font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size related party compound product other exercise license granted contravir pursuant section nbsp behalf contravir related party except each case extent such loss result from gross negligence willful misconduct chimerix indemnitee breach chimerix warranty representation covenant agreement made chimerix this agreement with respect loss which license indemnitee become subject result claim contravir shall comply with applicable requirement section nbsp license font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold indemnification chimerix font font size style font size chimerix hereby agrees save defend indemnify hold harmless contravir affiliate their respective officer director employee consultant agent style font weight bold contravir indemnitees from against loss which contravir indemnitee become subject result claim demand action other proceeding third party extent such loss arise relate nbsp gross negligence willful misconduct chimerix indemnitee nbsp breach chimerix warranty representation covenant agreement made chimerix this agreement nbsp exercise behalf chimerix affiliate licensee sublicensees license granted chimerix pursuant section nbsp applicable license granted chimerix pursuant section nbsp each case except extent such loss result from gross negligence willful misconduct contravir indemnitee breach contravir warranty representation covenant agreement made contravir this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold control defense font font size style font size event party style font weight bold indemnified party seek indemnification under section nbsp shall inform other party style font weight bold indemnifying party claim soon reasonably practicable after receives notice claim being understood agreed however that failure indemnified party give notice claim provided this section nbsp shall relieve indemnifying party indemnification obligation under this agreement except only extent that such indemnifying party actually damaged result such failure give notice shall permit indemnifying party assume direction control defense claim including right settle claim solely monetary consideration using counsel reasonably satisfactory indemnified party shall cooperate requested expense indemnifying party defense claim indemnifying party assume control such defense within nbsp after receiving notice claim from indemnified party indemnified party shall control such defense without limiting indemnifying party indemnification obligation indemnifying party shall reimburse indemnified party cost including reasonable attorney incurred indemnified party defending itself within nbsp after receipt invoice therefor from indemnified party party controlling such defense participate therein expense party controlling such defense shall keep other party advised status such action suit proceeding claim defense thereof shall consider recommendation made other party with respect thereto indemnified party shall agree settlement such action suit proceeding claim without prior written consent indemnifying party which shall unreasonably withheld delayed conditioned indemnifying party shall agree settlement such action suit proceeding claim consent judgment respect font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size thereof that include complete unconditional release indemnified party from liability with respect thereto that imposes liability obligation indemnified party that acknowledges fault indemnified party without prior written consent indemnified party party agree application section nbsp claim pending resolution dispute pursuant article nbsp party conduct separate defense such claim with each party retaining right claim indemnification from other party accordance with section nbsp applicable upon resolution underlying claim foregoing provision this section nbsp applicable claim which license indemnitee entitled indemnification under section nbsp shall subject section nbsp license contravir agrees comply with section nbsp license with respect claim which license indemnitee entitled indemnification under section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold insurance font font size style font size each party shall procure maintain insurance including comprehensive commercial general liability insurance including contractual liability product liability adequate cover obligation hereunder which consistent with normal business practice prudent company similarly situated provided however that contravir shall minimum obtain maintain insurance such type such amount required section nbsp nbsp license applicable section nbsp nbsp license shall comply with requirement section nbsp nbsp license applicable section nbsp nbsp through nbsp license understood that such insurance shall construed create limit either party liability with respect indemnification obligation under this article nbsp otherwise each party shall provide other party with written evidence such insurance upon request each party shall provide other party with written notice least nbsp prior cancellation renewal material change such insurance which materially adversely affect right other party hereunder font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold dispute resolution font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold dispute font font size style font size subject section nbsp claim dispute controversy breach enforcement interpretation validity this agreement each style font weight bold dispute will referred chief executive officer chimerix chief executive officer contravir attempted resolution event such executive unable resolve such dispute within nbsp such dispute being referred them then upon written request either party other party dispute shall subject arbitration accordance with section nbsp except expressly forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold arbitration font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold claim font font size style font size subject section nbsp below dispute that resolved under section nbsp within applicable period shall resolved final binding arbitration administered style font weight bold administrator accordance with then effective comprehensive arbitration rule nbsp procedure style font weight bold rule except extent such font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size rule nbsp conflict with express provision this section nbsp capitalized term used otherwise defined this agreement shall have meaning provided rule arbitration shall conducted neutral arbitrator selected accordance with rule provided that such individual shall current former employee director current stockholder either party their respective affiliate licensee sublicensee right granted such party under this agreement arbitration associated discovery proceeding communication shall conducted english arbitration shall held york font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold discovery font font size style font size within nbsp after selection arbitrator arbitrator shall conduct preliminary conference addressing subject within scope preliminary conference arbitrator shall take into account both desirability making discovery efficient cost effective need party understanding legitimate issue raised arbitration that regard party agree application discovery procedure forth rule nbsp nbsp expedited procedure addition each party shall have right take nbsp hour deposition testimony including expert deposition testimony font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold hearing decision font font size style font size hearing shall commence within nbsp after discovery cutoff arbitrator shall require that each party submit concise written statement position shall permit submission rebuttal statement subject reasonable limitation length such statement established arbitrator hearing shall longer than nbsp business duration arbitrator shall also permit submission expert report arbitrator shall render award within nbsp after arbitrator declares hearing closed award shall include written statement describing essential finding conclusion which award based including calculation damage awarded arbitrator will rendering decision apply substantive state york excluding conflict principle with exception section nbsp york general obligation arbitrator authority award special incidental consequential punitive damage shall subject limitation forth section nbsp award rendered arbitrator shall final binding appealable judgment entered upon court competent jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cost font font size style font size each party shall bear attorney cost disbursement arising arbitration shall equal share cost arbitrator provided however arbitrator shall authorized determine whether party prevailing party award that prevailing party reimbursement reasonable attorney cost disbursement including example expert witness expense photocopy charge travel expense nbsp cost administrator arbitrator font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold court action font font size style font size nothing contained this agreement shall deny either party right seek injunctive other equitable relief from court competent jurisdiction context bona fide emergency prospective irreparable harm such action font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size filed maintained notwithstanding ongoing discussion between party ongoing arbitration proceeding addition either party bring action court competent jurisdiction resolve dispute pertaining validity construction scope enforceability infringement other violation patent right other intellectual property right such claim shall subject arbitration pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold miscellaneous font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold right upon bankruptcy font font size style font size right license granted under pursuant this agreement shall otherwise deemed purpose section nbsp nbsp title nbsp united state code other similar jurisdiction outside collectively style font weight bold bankruptcy license right intellectual property defined under bankruptcy case commenced during term against party under bankruptcy then unless until this agreement rejected provided such bankruptcy such party capacity including debtor possession successor assigns including trustee shall perform obligation provided this agreement performed such party case commenced during term against party under bankruptcy this agreement rejected provided bankruptcy other party elect retain right hereunder provided bankruptcy then party subject such case under bankruptcy capacity including debtor possession successor assigns including title nbsp trustee shall provide other party copy information necessary such other party prosecute maintain enjoy right under term this agreement promptly upon such other party written request therefor right power remedy bankrupt party provided herein addition substitution other right power remedy hereafter existing equity including without limitation bankruptcy event commencement case against party under bankruptcy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold governing font font size style font size this agreement shall governed construed accordance with state york excluding conflict principle with exception section nbsp york general obligation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold entire agreement amendment font font size style font size this agreement including exhibit hereto both final expression party agreement complete exclusive statement with respect term this agreement supersedes prior contemporaneous agreement communication whether oral written otherwise concerning matter contained herein exhibit this agreement incorporated herein reference shall deemed part this agreement this agreement amended term hereof modified only written instrument duly executed authorized representative both party hereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold waiver font font size style font size failure party insist upon strict performance provision this agreement exercise right arising this agreement shall neither impair that provision right constitute waiver that provision right whole font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size part that instance other instance waiver party particular provision right shall writing shall particular matter applicable particular period time shall signed such party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold assignment font font size style font size except expressly provided hereunder neither this agreement right obligation hereunder assigned otherwise transferred either party without prior written consent other party which consent shall unreasonably withheld provided however that either party assign this agreement right obligation hereunder without other party consent font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size connection with transfer sale substantially business such party which this agreement relates third party style font weight bold third party acquirer whether merger sale stock sale asset otherwise each style font weight bold sale transaction provided that event sale transaction whether this agreement actually assigned assumed third party acquirer surviving corporation resulting from such sale transaction operation context reverse triangular merger intellectual property right third party acquirer that existed prior sale transaction shall included technology licensed hereunder otherwise subject this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size affiliate provided that assigning party shall remain liable responsible assigning party hereto performance observance such duty obligation such affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size right obligation party under this agreement shall binding upon inure benefit successor permitted assigns party name party appearing herein will deemed include name such party successor permitted assigns extent necessary carry intent this section assignment accordance with this agreement shall void font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold force majeure font font size style font size except obligation make payment when each party shall excused from liability failure delay performance obligation under this agreement reason event beyond such party reasonable control including limited fire flood explosion earthquake other natural force civil unrest terrorism accident destruction other casualty lack failure transportation facility lack failure supply material strike labor disturbance other event similar those enumerated above such excuse from liability shall effective only extent duration event nbsp causing failure delay performance provided that party caused such event nbsp occur affected party shall notify other party such force majeure circumstance soon reasonably practical shall promptly undertake reasonable effort necessary cure such force majeure circumstance font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold severability font font size style font size more provision contained this agreement held invalid illegal unenforceable respect validity legality enforceability remaining provision contained herein shall affected impaired thereby font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size unless absence invalidated provision nbsp adversely affect substantive right party party shall such instance their best effort replace invalid illegal unenforceable provision nbsp with valid legal enforceable provision nbsp which insofar practical implement purpose this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold notice font font size style font size notice which required permitted hereunder shall writing sufficient delivered personally sent facsimile promptly confirmed personal delivery registered certified mail overnight courier sent nationally recognized overnight courier sent registered certified mail postage prepaid return receipt requested addressed follows font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size chimerix font font size style font size font font size style font size chimerix nbsp font style margin font size face time roman style font size meridian parkway font style margin font size face time roman style font size suite nbsp font style margin font size face time roman style font size durham font style margin font size face time roman style font size font style margin font size face time roman style font size attn font font size style font size nbsp nbsp font font size style font size legal department font style margin font size face time roman style font size facsimile font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size contravir font font size style font size font font size style font size contravir pharmaceutical nbsp font style margin font size face time roman style font size thornall street first floor font style margin font size face time roman style font size edison jersey font style margin font size face time roman style font size font style margin font size face time roman style font size attn font font size style font size nbsp nbsp font font size style font size james sapirstein font style margin font size face time roman style font size facsimile font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size with copy font font size style font size font font size style font size lowenstein sandler font style margin font size face time roman style font size livingston avenue font style margin font size face time roman style font size roseland jersey font style margin font size face time roman style font size font style margin font size face time roman style font size attn font font size style font size nbsp nbsp font font size style font size michael lerner font style margin font size face time roman style font size facsimile font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size such other address party whom notice given have furnished other party writing accordance herewith such notice shall deemed have been given nbsp when delivered personally delivered sent facsimile business delivered sent business then next business nbsp business after dispatch sent nationally recognized overnight courier nbsp third business following date mailing sent mail font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold interpretation font font size style font size heading clause contained this agreement preceding text section subsection paragraph hereof inserted solely convenience ease reference only shall constitute part this agreement have effect interpretation construction reference this agreement singular shall include plural where applicable term including includes used this agreement mean including without limiting generality description preceding such font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size term word inclusive meaning represented phrase unless otherwise specified reference this agreement section shall include subsection paragraph such section nbsp reference this agreement subsection shall include paragraph such subsection reference this agreement shall mean calendar unless otherwise specified ambiguity uncertainty this agreement shall interpreted against either party irrespective which party deemed have caused ambiguity uncertainty exist this agreement been prepared english language english language shall control interpretation addition notice required permitted given hereunder written electronic oral other communication between party regarding this agreement shall english language font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold relationship between party font font size style font size party relationship established this agreement solely that independent contractor this agreement create partnership joint venture similar business relationship between party neither party legal representative other party neither party assume create obligation representation warranty guarantee express implied behalf other party purpose whatsoever font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold cumulative remedy font font size style font size remedy referred this agreement intended exclusive each shall cumulative addition other remedy referred this agreement otherwise available under font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold third party right font font size style font size provision this agreement exclusive benefit party other person entity shall have right claim against party reason these provision entitled enforce these provision against party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold font font size style font size font weight bold font font size style font size font weight bold counterpart font font size style font size this agreement executed counterpart each which shall deemed original document which together with this writing shall deemed instrument this agreement executed facsimile signature which signature shall have same force effect original signature font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font style italic remainder this page nbsp intentionally left blank font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold certain portion this exhibit nbsp have been omitted based upon request confidential treatment public information been filed with security exchange commission font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold witness whereof font font size style font size party hereto have duly executed this license agreement effective date font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width colspan valign style padding width style margin font size face time roman style font size font weight bold chimerix nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold contravir pharmaceutical nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size name font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size name font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size title font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size title font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp font height width style border none width style border none width style border none width style border none width style border none width style border none width style border none width style border none width style border none table align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size exhibit name font style margin size width noshade color align left folio exhibit file task user body html text document